GB1449333A - Fractionation of blood - Google Patents
Fractionation of bloodInfo
- Publication number
- GB1449333A GB1449333A GB355774A GB355774A GB1449333A GB 1449333 A GB1449333 A GB 1449333A GB 355774 A GB355774 A GB 355774A GB 355774 A GB355774 A GB 355774A GB 1449333 A GB1449333 A GB 1449333A
- Authority
- GB
- United Kingdom
- Prior art keywords
- treated
- block copolymer
- serum
- concentration
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 238000005194 fractionation Methods 0.000 title 1
- 229920001400 block copolymer Polymers 0.000 abstract 7
- 210000002381 plasma Anatomy 0.000 abstract 5
- 210000002966 serum Anatomy 0.000 abstract 5
- 108010017384 Blood Proteins Proteins 0.000 abstract 2
- 102000004506 Blood Proteins Human genes 0.000 abstract 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 abstract 2
- 239000002244 precipitate Substances 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102100027378 Prothrombin Human genes 0.000 abstract 1
- 108010094028 Prothrombin Proteins 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 229940019700 blood coagulation factors Drugs 0.000 abstract 1
- 238000010261 blood fractionation Methods 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 229940039716 prothrombin Drugs 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32789373A | 1973-01-30 | 1973-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1449333A true GB1449333A (en) | 1976-09-15 |
Family
ID=23278536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB355774A Expired GB1449333A (en) | 1973-01-30 | 1974-01-25 | Fractionation of blood |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS49102820A (enrdf_load_stackoverflow) |
| AU (1) | AU6495474A (enrdf_load_stackoverflow) |
| BE (1) | BE810217A (enrdf_load_stackoverflow) |
| CA (1) | CA984748A (enrdf_load_stackoverflow) |
| DE (1) | DE2403065A1 (enrdf_load_stackoverflow) |
| ES (1) | ES422767A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2215241B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1449333A (enrdf_load_stackoverflow) |
| IL (1) | IL44023A (enrdf_load_stackoverflow) |
| ZA (1) | ZA74350B (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783441A (en) * | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3944391A (en) * | 1974-12-27 | 1976-03-16 | Preventive Systems, Inc. | In vitro process for detecting endotoxin in a biological fluid |
| IL49752A (en) * | 1975-07-09 | 1979-07-25 | Kabi Ab | Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration |
| DK25877A (da) * | 1977-01-21 | 1978-08-15 | Nordisk Insulinlab | Fremgangsmaade til udvinding af renset albumin fra blodplasma |
| JPS5843369B2 (ja) * | 1977-09-10 | 1983-09-27 | 森六株式会社 | 血清蛋白質の分画方法 |
-
1974
- 1974-01-17 ZA ZA740350A patent/ZA74350B/xx unknown
- 1974-01-20 IL IL44023A patent/IL44023A/en unknown
- 1974-01-21 JP JP49009169A patent/JPS49102820A/ja active Pending
- 1974-01-23 DE DE2403065A patent/DE2403065A1/de not_active Withdrawn
- 1974-01-25 GB GB355774A patent/GB1449333A/en not_active Expired
- 1974-01-28 BE BE140217A patent/BE810217A/xx unknown
- 1974-01-29 AU AU64954/74A patent/AU6495474A/en not_active Expired
- 1974-01-29 CA CA191,229A patent/CA984748A/en not_active Expired
- 1974-01-29 FR FR7402807A patent/FR2215241B1/fr not_active Expired
- 1974-01-30 ES ES422767A patent/ES422767A1/es not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783441A (en) * | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
Also Published As
| Publication number | Publication date |
|---|---|
| CA984748A (en) | 1976-03-02 |
| BE810217A (fr) | 1974-05-16 |
| IL44023A0 (en) | 1974-05-16 |
| FR2215241B1 (enrdf_load_stackoverflow) | 1977-03-11 |
| JPS49102820A (enrdf_load_stackoverflow) | 1974-09-28 |
| IL44023A (en) | 1977-05-31 |
| DE2403065A1 (de) | 1974-08-01 |
| ES422767A1 (es) | 1976-06-01 |
| ZA74350B (en) | 1974-11-27 |
| FR2215241A1 (enrdf_load_stackoverflow) | 1974-08-23 |
| AU6495474A (en) | 1975-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marchesi et al. | Studies on the purification and characterization of human factor VIII | |
| De Marco et al. | Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent. | |
| Handin et al. | Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome | |
| Edwards et al. | Tri (n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives | |
| Kronvall et al. | Protein A reactivity with mouse immunoglobulins: structural relationship between some mouse and human immunoglobulins | |
| Müller-Eberhard et al. | Isolation of the anticomplementary protein from cobra venom and its mode of action on C3 | |
| Sixma et al. | Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition | |
| Jaffe et al. | Synthesis of von Willebrand factor by cultured human endothelial cells | |
| Agre et al. | A molecular defect in two families with hemolytic poikilocytic anemia: reduction of high affinity membrane binding sites for ankyrin. | |
| Ohmori et al. | Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function. | |
| Mohri et al. | Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor | |
| Yagi et al. | Monoclonal IgA and IgM in the serum of a single patient (SC) I. Sharing of individually specific determinants between IgA and IgM | |
| Fahey | Immunochemical studies of twenty mouse myeloma proteins: evidence for two groups of proteins similar to gamma and beta-2A globulins in man | |
| Mosesson et al. | Human platelet fibrinogen gamma chain structure | |
| GB1449333A (en) | Fractionation of blood | |
| Dawson et al. | Assay discrepancies with highly purified factor VIII concentrates | |
| Baugh et al. | Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity | |
| Clezardin et al. | Isolation of thrombospondin released from thrombinstimulated human platelets by fast protein liquid chromatography on an anion-exchange mono-q column | |
| Matsuda et al. | Cryofibrinogen in the plasma of patients with skin ulcerative lesions on the legs: a complex of fibrinogen and cold insoluble globulin | |
| Booth et al. | An altered platelet granule glycoprotein in patients with essential thrombocythemia. | |
| Gralnick et al. | Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A | |
| Ziegler et al. | Genetic polymorphism of properdin factor B in the rhesus: evidence for single subunit structure in primates | |
| Aronson | The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia A | |
| Masci et al. | Fibrinolysis as a feature of disseminated intravascular coagulation (DIC) after Pseudonaja textilis textilis envenomation | |
| Sanchez-Avalos et al. | Degradation of fibrinogen by proteolytic enzymes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |